Intensive Care Unit, Royal Children's Hospital, Melbourne, Australia.
Clin Ther. 2013 Feb;35(2):109-14. doi: 10.1016/j.clinthera.2013.01.007. Epub 2013 Jan 31.
There is now strong evidence that vaccines have substantial nonspecific (heterologous) effects in children in high-mortality regions. The hypothesis states that, until a different vaccine is given: (1) live vaccines induce a protective nonspecific immune response, whereas inactivate vaccines cause a harmful nonspecific immune response; (2) Bacillus Calmette-Guerin (BCG) vaccine approximately halves mortality from infections other than tuberculosis; (3) provided vitamin A was not given at birth, measles vaccine approximately halves mortality from infections other than measles (this effect may be stronger if the child still has maternal antibody); and (4) whole-cell diphtheria-tetanus-pertussis (DTP) vaccine increases mortality from infections other than diphtheria, tetanus, and pertussis (this effect is stronger in girls than boys). These observations suggest that minor modifications to the routine immunization schedule could reduce child mortality by at least 30%, and they have important implications for the design of randomized trials of vaccines in high-mortality regions.
现在有强有力的证据表明,疫苗对高死亡率地区的儿童具有实质性的非特异性(异源)作用。该假说指出,在接种另一种疫苗之前:(1)活疫苗会诱导保护性的非特异性免疫反应,而灭活疫苗则会引起有害的非特异性免疫反应;(2)卡介苗(BCG)疫苗可使除结核病以外的感染导致的死亡率降低约一半;(3)如果在出生时未给予维生素 A,则麻疹疫苗可使除麻疹以外的感染导致的死亡率降低约一半(如果孩子仍有母体抗体,这种效果可能更强);以及(4)全细胞白喉-破伤风-百日咳(DTp)疫苗会增加除白喉、破伤风和百日咳以外的感染导致的死亡率(这种效果在女孩中比男孩更强)。这些观察结果表明,对常规免疫接种计划进行微小修改,至少可以将儿童死亡率降低 30%,这对在高死亡率地区设计疫苗随机试验具有重要意义。